GALMED PHARMACEUTICALS LTD (GLMD) Stock Cash Flow
NASDAQ:GLMD - Nasdaq - IL0011313900 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -6.32M | -6.91M | -17.87M | -32.47M | -28.77M | |||
| Depreciation Amortization | 89.00K | 31.00K | 40.00K | 40.00K | 40.00K | |||
| Change In Working Capital | 852.00K | 132.00K | -2.45M | -2.45M | 1.10M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 574.00K | 612.00K | 1.78M | 1.98M | 1.34M | |||
| OPERATING CASH FLOW | -4.81M | -6.14M | -18.50M | -32.89M | -26.29M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | 0.00 | -10.00K | -40.00K | |||
| Other Investing Activity | 4.72M | 800.00K | 17.57M | 11.47M | 16.58M | |||
| INVESTING CASH FLOW | 4.72M | 800.00K | 17.56M | 11.46M | 16.54M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 6.18M | 70.00K | 17.37M | 770.00K | |||
| FINANCING CASH FLOW | N/A | 6.18M | 70.00K | 17.37M | 770.00K | |||
| CHANGE IN CASH | 8.25M | 848.00K | -870.00K | -4.06M | -8.98M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.81M | -6.14M | -18.50M | -32.89M | -26.29M | |||
| Capital Expenditure | N/A | 0.00 | 0.00 | -10.00K | -40.00K | |||
| FREE CASH FLOW | -4.81M | -6.14M | -18.50M | -32.90M | -26.33M | |||
All data in USD